Business Description
Biofrontera Inc
NAICS : 325411
SIC : 2834
ISIN : US09077D2099
Description
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. Its licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. Its licensed product is Ameluz, which is a prescription drug approved for use in combination with the RhodoLED lamp series, for PDT (when used together, Ameluz PDT). including the complementary product BF-RhodoLED, and Xepi.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3.05 | |||||
| Equity-to-Asset | 0.51 | |||||
| Debt-to-Equity | 0.13 | |||||
| Debt-to-EBITDA | -0.15 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -6.5 | |||||
| Beneish M-Score | -2.8 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -12.1 | |||||
| 3-Year EBITDA Growth Rate | 2.5 | |||||
| 3-Year EPS without NRI Growth Rate | 5.7 | |||||
| 3-Year FCF Growth Rate | 8.9 | |||||
| 3-Year Book Growth Rate | -32 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 20.75 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 12-1 Month Momentum % | -35.07 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.89 | |||||
| Quick Ratio | 1.46 | |||||
| Cash Ratio | 0.47 | |||||
| Days Inventory | 208.55 | |||||
| Days Sales Outstanding | 37.64 | |||||
| Days Payable | 116.02 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -37.8 | |||||
| Shareholder Yield % | -36.8 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 47.75 | |||||
| Operating Margin % | -51.65 | |||||
| Net Margin % | -38.33 | |||||
| FCF Margin % | -53.68 | |||||
| ROE % | -365.15 | |||||
| ROA % | -46.56 | |||||
| ROIC % | -119.71 | |||||
| 3-Year ROIIC % | -838.82 | |||||
| ROC (Joel Greenblatt) % | -218.65 | |||||
| ROCE % | -112.4 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.06 | |||||
| PB Ratio | 0.4 | |||||
| Price-to-Tangible-Book | 0.52 | |||||
| EV-to-EBIT | -0.16 | |||||
| EV-to-EBITDA | -0.18 | |||||
| EV-to-Revenue | 0.05 | |||||
| EV-to-Forward-Revenue | 0.08 | |||||
| EV-to-FCF | -0.09 | |||||
| Price-to-Net-Current-Asset-Value | 0.64 | |||||
| Earnings Yield (Greenblatt) % | -625 | |||||
| FCF Yield % | -399.79 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Biofrontera Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 32.614 | ||
| EPS (TTM) (€) | -4.348 | ||
| Beta | 0 | ||
| Volatility % | 34.37 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (€) | 0 | ||
| 20-Day SMA (€) | 9.74 | ||
| 12-1 Month Momentum % | -35.07 | ||
| 52-Week Range (€) | 7.26 - 15.1 | ||
| Shares Outstanding (Mil) | 1.68 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Biofrontera Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Biofrontera Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Biofrontera Inc Frequently Asked Questions
What is Biofrontera Inc(FRA:AI10)'s stock price today?
The current price of FRA:AI10 is €9.74. The 52 week high of FRA:AI10 is €15.10 and 52 week low is €7.26.
When is next earnings date of Biofrontera Inc(FRA:AI10)?
The next earnings date of Biofrontera Inc(FRA:AI10) is .
Does Biofrontera Inc(FRA:AI10) pay dividends? If so, how much?
Biofrontera Inc(FRA:AI10) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers